期刊文献+

三级甲等医院指导下慢性心力衰竭患者的社区管理研究 被引量:30

Community-based management for chronic heart failure patients under the professional guidance of upper first-class hospital staff
原文传递
导出
摘要 目的建立一个三级甲等医院指导下慢性心力衰竭患者的社区管理模式。方法以成都市青羊区苏坡社区和周边新都区城东社区两个区域作为研究基地,入选200例35—85岁NYHA心功能分级Ⅱ-Ⅳ级的慢性心力衰竭患者。以街道和小区为基本单元,采用整群随机分组方法,将其分为干预组(共11个自然居民小区,100例患者)和对照组(共11个自然居民小区,100例患者)。三级甲等医院对青羊区苏坡社区和新都区城东社区医院医生(22名)进行标准化心力衰竭诊治培训,医生参与干预组的随访管理;同期对干预组患者进行分次自我管理教育。对照组不进行任何干预。主要随访指标包括社区医生对心力衰竭的知晓率、诊断阳性率、对标准化治疗的接受程度;患者心力衰竭的知晓率、服药率、标准化药物使用率、自我管理能力、生活质量、心血管事件、住院时间和医疗花费。结果标准化心力衰竭诊治培训后,社区医生心力衰竭的知晓率[培训前后心力衰竭药物治疗和生活指导分别为13.6%(3/22)和100%(22/22),心力衰竭病因相关防治知识分别为22.7%(5/22)和100%(22/22)]、诊断阳性率[培训前后分别为51.8%(100/193)和87.0%(168/193)]、标准化治疗接受程度[培训前后B受体阻滞剂分别为22.7%(5/22)和77.3%(17/22),血管紧张素转换酶抑制剂分别为27.2%(6/22)和63.6%(14/22)]均较培训前增高(P均〈0.05)。干预组有效患者96例,对照组有效患者97例。随访时间为(18.5±0.5)个月。干预组患者的疾病知晓率[100%(96/96)比71.1%(69/97)]、服药率[78.1%(75/96)比13.4%(13/97)]、标准化药物使用率[β受体阻滞剂75.0%(72/96)比8.2%(8/97),血管紧张素转换酶抑制剂60.4%(58/96)比10.3%(10/97)]、自我日常生活管理率[限盐、控制饮食88.5%(85/96)比29.9%(23/97)、监测血压83.3%(80/96)比56.7%(55/97)、监测体质量78.1%(75/96)比13.4%(13/97)]均高于对照组(P均〈0.05)。在61例心功能Ⅲ~Ⅳ级患者中,干预组的生活质量量表总分[(43.7±9.2)分比(49.5±11.3)分]、心血管事件发生率[63.3%(19/30)比90.3%(28/31)]、住院时间[(8.2±3.2)d比(13.9±10.9)d]、住院总费用[(2873.3±401.6)元比(4525.8±6417.8)元]均低于对照组(P均〈0.05)。结论三级甲等医院指导下慢性心力衰竭患者的社区管理模式通过提高社区医生对慢性心力衰竭诊治进展及社区疾病管理控制方案的知晓率及执行度,提高患者对慢性心力衰竭的认知率及疾病自我管理能力,改善了患者服药率和遵医行为,有望在远期获得良好的卫生经济学效益。 Objective To establish a community-based management model for heart failure patients under the professional guidance of upper first-class hospital staff. Methods Two hundreds heart failure ( New York Heart Function Ⅱ - Ⅳ) patients aged from 35 to 85 in two communities of Chengdu city were divided into two groups by cluster randomization: the management group and the control group. The community hospital doctors were trained for the evaluation and management of heart failure according standardized guidelines by upper first-class hospital doctors, and responsible for the management of patients in the management group. Meanwhile, the management group patients also received self-care education. Patients in control group were treated by community doctors without special training. Data including the community hospital doctors' knowledge rate of heart failure, positive diagnosis rate, and the rate for standardized medication for heart failure; the patients' knowledge rate of heart failure, the rate of drug compliance, the rate of standardized drug taken for heart failure, the rate of self-care in daily-life, the quality of life, the incidence of cardiovascular events, hospitalization time and cost were compared between the two groups. Results The community hospital doctors' knowledge rate of heart failure, the related knowledge for prevention and treatment on the causes of heart failure, the positive diagnosis rate, and the rate for standardized medication for heart failure [ β receptor blocker 77.3% (17/22); angiotensinconverting enzyme inhibitors 63.6% ( 14/22 ) ] were significantly higher than doctors in the control group ( all P 〈 0. 05 ). There were 96 in the management group and 97 in the control group. Data were similar between the two groups at baseline. After (18.5 ± 0. 5 )months, the patient's knowledge rate of heart failure [ 100% (96/96) vs. 71.1% (69/97) ], the rate of drug compliance[78.1% (75/96) vs. 13.4% ( 13/ 97) ] , the rate of standardized drug taken for heart failure[β receptor blocker: 75.0% (72/96) vs. 8.2% ( 8/97 ) ; angiotensin-eonverting enzyme inhibitors : 60. 4% (58/96) vs. 10. 3% ( 10/97 ) ], and the rate of self-care in daily-life [ salt and food restriction: 88.5% (85/96) vs. 29.9% (23/97); blood pressure monitoring:83.3% (80/96) vs. 56.7% (55/97) ; weight monitoring: 78.1% (75/96) vs. 13.4% ( 13/ 97) ] were all significantly higher in the management group than in control group. For patients with New York Heart Function Ⅲ - Ⅳ, the score of the LiHFe questionnaire (43.7 ± 9.2 vs. 49.5 ±11.3 ) , the incidence of cardiovascular events [ 63.3% ( 19/30 ) vs. 90. 3% (28/31) ] , the days of hospitalization [ (8. 2±3.2)days vs. (13.9 + 10. 9)days] ,and the cost for hospitalization[ (2873.3 ±401.6) Yuan vs. (4525.8 ±6417.8 ) Yuan ] were all significantly lower in the management group( n = 30) than in the control group ( n = 31 ) ( all P 〈 0. 05 ). Conclusions The community-based management model for heart failure patients in the community level is effective to improve the management and outcome in this cohort.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第11期939-944,共6页 Chinese Journal of Cardiology
基金 成都市“十一五”科技攻关重大项目(07YTYB957SF-020)
关键词 心力衰竭 充血性 疾病管理 社区医学 Heart failure, congestive Disease management Community medicine
  • 相关文献

参考文献9

  • 1顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1278
  • 2蔡琳,燕纯伯.心力衰竭的社区防治现状及进展[J].心血管病学进展,2007,28(5):732-734. 被引量:12
  • 3Whellan DJ. Heart failure disease management: implementation and outcomes. Cardiol Rev,2005, 13:231-239.
  • 4Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet, 2011, 378: 731-739.
  • 5Pazin-Filho A, Peitz P, Pianta T, et al. Heart failure disease management program experience in 4545 heart failure admissions to a community hospital. Am Heart J,2009, 158:459.466.
  • 6Bonarek-Hessamfar M, Benchimol D, Lauribe P, et al. Multidisciplinary network in heart failure management in a community-based population: results and benefits at 2 years. Int J Cardiol,2009, 134 : 120-122.
  • 7奚悦文,范维琥.明尼苏达心力衰竭生活质量调查表适用性的评价[J].上海医学,2004,27(4):222-225. 被引量:170
  • 8Hunt SA, Baker DW, Chin MH,et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure ): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation,2001, 104: 2996-3007.
  • 9Riegel B, Moser DK, Anker SD, et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation,2009, 120:1141-1163.

二级参考文献39

  • 1Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol, 1994, 74: 1240-1244.
  • 2Rector T, Kubo S, Cohn J. Patient's self-assessment of their congestive heart failure. Part2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure, 1987, 3: 198-209.
  • 3Riegel B, Moser DK, Glaser D, et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population.Nurs Res, 2002, 51: 209-218.
  • 4Middel B, Bouma J, de Jongste M, et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire(MLHF-Q). Clin Rehabil, 2001, 15: 489-500.
  • 5Ni H, Toy W, Burgess D, et al. Comparative responsiveness of Short-Form 12 and Minnesota Living With Heart Failure Questionnaire in patients with heart failure. J Card Fail, 2000, 6: 83-91.
  • 6Sneed NV, Paul S, Michel Y, et al. Evaluation of 3 quality of life measurement tools in patients with chronic heart failure.Heart Lung, 200l, 30:332-340.
  • 7Smith RF, Johnson G, Ziesche S, et al. Functional capacity in heart failure : Comparison of methods for assessment and their relation to other indexes of heart failure. Circulation, 1993, 87(suppl 6): Ⅵ88-Ⅵ93.
  • 8Gorkin L, Norvell NK, Rosen RC, et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of life substudy.Am J Cardiol, 1993, 71: 1069-1073.
  • 9Cowley AJ, Wiens BL, Segal R, et al. Randomised comparison of losartan vs. Captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy. Qual Life Res, 2000, 9: 377-384.
  • 10Alla F, Briancon S, Guillemin F, et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail, 2002, 4:337-343.

共引文献1442

同被引文献239

引证文献30

二级引证文献274

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部